We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
US-based artificial intelligence (AI)-driven gene therapy specialist Dyno Therapeutics has secured $100m in a Series A financing round led by venture capital firm Andreessen Horowitz. The funding round
Health Canada has expanded the interim order authorisation for the use of Pfizer-BioNTech Covid-19 vaccine, BNT162b2, in children aged 12 to 15 years. With the approval, BNT162b2 becomes
Swiss healthcare firm Roche has received the European Commission approval for its Tecentriq (atezolizumab) as a first-line monotherapy treatment for people with a type of metastatic non-small cell
Pfizer has reported a net income of $4.8bn, or $0.86 per diluted share, for the first quarter of 2021, a 45% increase compared to $3.3bn, or $0.60 per
US-based biopharmaceutical firm Athenex has agreed to acquire Kuur Therapeutics, a developer of off-the-shelf CAR-NKT cell immunotherapies that will help treat solid and haematological malignancies, for a total
Roivant Sciences, a Swiss healthcare tech firm, has agreed to merge with Montes Archimedes Acquisition Corporation (MAAC) in a deal that values the Swiss company at $7.3bn. The
Aceragen, a US-based biopharmaceutical company, has acquired Enzyvant’s investigational therapy, RVT-801 (now ACG-801), to treat Farber disease. Farber disease is a lysosomal storage disease with a severe inflammatory
The Dutch government has suspended the use of AstraZeneca’s coronavirus vaccine for two weeks following possible side effects reported in Denmark and Norway. The suspension, which will last
US-based health care services firm Cardinal Health has agreed to divest its Cordis business to Hellman & Friedman (H&F) for about $1bn. Cordis is a developer and manufacturer
The Therapeutic Goods Administration (TGA), the regulatory body for therapeutic goods in Australia, has provisionally approved the Covid-19 vaccine of Pfizer and BioNTech for use in Australia. The